Sort by:
298 products
298 products
ROSUVASTATIN
Active ingredient: Rosuvastatin
Concentration: 10MG
Presentation: 30 Tablets
Laboratory: AMSA
Origin: Made in Mexico
High-potency generic statin indicated for reducing elevated levels of "bad" LDL cholesterol and triglycerides, with a positive effect on "good" HDL. It inhibits the HMG-CoA reductase enzyme, reducing hepatic cholesterol synthesis. It helps prevent cardiovascular complications such as heart attack and stroke in at-risk patients.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
DYLAXYL
Active ingredient: Atorvastatin
Concentration: 10MG
Presentation: 20 Tablets
Laboratory: SONS
Origin: Made in Mexico
Statin indicated to reduce high levels of LDL ("bad") cholesterol and triglycerides, with a positive effect on HDL ("good") cholesterol. It inhibits the HMG-CoA reductase enzyme, reducing hepatic cholesterol synthesis. It helps prevent cardiovascular complications such as heart attack and stroke in at-risk patients.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
BIONOLIP
Active substance: Bezafibrate
Concentration: 200MG
Presentation: 30 Tablets
Laboratory: BIORESEARCH
Origin: Made in Mexico
Fibrate indicated for the treatment of elevated triglyceride levels and dyslipidemia in patients who do not respond adequately to other treatments. It works by activating PPAR-alpha receptors, reducing hepatic fat production and promoting its breakdown in the blood. Contributes to reducing the risk of pancreatitis and cardiovascular events associated with dyslipidemia.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
GEMFIBROZIL
Active ingredient: Gemfibrozil
Concentration: 600MG
Presentation: 14 Tablets
Laboratory: TEMPUSPHARMA
Origin: Made in Mexico
Fibrate indicated for the treatment of elevated triglyceride levels and mixed dyslipidemia. It acts by activating PPAR-alpha receptors, reducing hepatic triglyceride production and promoting their elimination from the blood. It helps reduce the risk of pancreatitis and cardiovascular events associated with hypertriglyceridemia.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
COLLIPROL (Atorvastatin) 40 mg
Active substance: Atorvastatin
Concentration: 40 mg
Presentation: 15 tablets
Laboratory: COLLINS
Origin: Made in Mexico
Atorvastatin is a high-potency statin that inhibits the HMG-CoA reductase enzyme, reducing hepatic synthesis of LDL cholesterol and triglycerides, and increasing HDL. It is indicated for the treatment of hypercholesterolemia, mixed dyslipidemia, and for the prevention of major cardiovascular events such as myocardial infarction and stroke in patients with risk factors.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Atorvastatin 20 mg
Active ingredient: Atorvastatin
Concentration: 20 mg
Presentation: 10 tablets
Laboratory: MEDIGEN
Origin: Made in Mexico
Atorvastatin is a statin that inhibits the HMG-CoA reductase enzyme, reducing hepatic synthesis of LDL cholesterol and triglycerides, and increasing HDL. It is indicated for the treatment of hypercholesterolemia, mixed dyslipidemia, and for the prevention of major cardiovascular events such as myocardial infarction and stroke in patients with risk factors.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
FIROLIB
Active ingredient: Fenofibrate
Concentration: 160MG
Presentation: 30 Tablets
Laboratory: APOTEX
Origin: Made in Mexico
Fibrate indicated for the treatment of hypertriglyceridemia and mixed dyslipidemia. It acts by activating PPAR-alpha receptors, reducing hepatic triglyceride production and increasing their elimination in the blood, with a positive effect on HDL. It helps to decrease the risk of pancreatitis and cardiovascular events associated with dyslipidemia.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
KAZIMIBE (Ezetimibe) 10 mg
Active ingredient: Ezetimibe
Concentration: 10 mg
Presentation: 28 tablets
Laboratory: SOLFRAN
Origin: Made in Mexico
Ezetimibe selectively inhibits the intestinal absorption of cholesterol and phytosterols in the small intestine, reducing total cholesterol and LDL levels in plasma. It is indicated for the treatment of primary hypercholesterolemia, alone or in combination with statins, and in patients who do not achieve their lipid targets with diet or statin monotherapy.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
CROSTOX (Rosuvastatin) 20 mg
Active substance: Rosuvastatin
Concentration: 20 mg
Presentation: 30 tablets
Laboratory: MAVI
Origin: Made in Mexico
Rosuvastatin is a high-potency statin that selectively inhibits the HMG-CoA reductase enzyme, reducing hepatic synthesis of LDL cholesterol and triglycerides, and increasing HDL. It is indicated for the treatment of primary hypercholesterolemia, mixed dyslipidemia, and for the prevention of major cardiovascular events in patients with high cardiovascular risk factors.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
TROMDEX (Ezetimibe) 10 mg
Active substance: Ezetimibe
Concentration: 10 mg
Presentation: 30 tablets
Laboratory: RAAM
Origin: Made in Mexico
Ezetimibe selectively inhibits the intestinal absorption of cholesterol and phytosterols in the small intestine, reducing total cholesterol and LDL levels in plasma. It is indicated for the treatment of primary hypercholesterolemia, alone or in combination with statins, and in patients who do not reach their lipid targets with diet or statin monotherapy.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
LOPID (Gemfibrozil) 600 mg
Active ingredient: Gemfibrozil
Concentration: 600 mg
Presentation: 14 tablets
Laboratory: PFIZER
Origin: Made in Mexico
Gemfibrozil is a fibrate that works by activating PPAR-alpha receptors, stimulating lipoprotein lipase, and reducing hepatic synthesis of triglycerides and VLDL. It is indicated for the treatment of severe hypertriglyceridemia and mixed dyslipidemia, especially in patients at risk of pancreatitis or cardiovascular events associated with elevated triglyceride levels.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
XANTEROK (Simvastatin) 20 mg
Active substance: Simvastatin
Concentration: 20 mg
Presentation: 30 tablets
Laboratory: KENER
Origin: Made in Mexico
Simvastatin is a statin that inhibits the HMG-CoA reductase enzyme, reducing hepatic synthesis of LDL cholesterol and triglycerides, and increasing HDL. It is indicated for the treatment of primary hypercholesterolemia and mixed dyslipidemia, as well as for the prevention of major cardiovascular events such as myocardial infarction and stroke in patients with high cardiovascular risk.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
CROSTOX (Rosuvastatin) 10 mg
Active ingredient: Rosuvastatin
Concentration: 10 mg
Presentation: 30 tablets
Laboratory: MAVI
Origin: Made in Mexico
Rosuvastatin is a high-potency statin that selectively inhibits the HMG-CoA reductase enzyme, reducing hepatic synthesis of LDL cholesterol and triglycerides, and increasing HDL. It is indicated for the treatment of primary hypercholesterolemia, mixed dyslipidemia, and for the prevention of major cardiovascular events in patients with high cardiovascular risk factors.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Rosuvastatin 20 mg
Active substance: Rosuvastatin
Concentration: 20 mg
Presentation: 15 tablets
Laboratory: AMSA
Origin: Made in Mexico
Rosuvastatin is a high-potency statin that selectively inhibits the HMG-CoA reductase enzyme, reducing hepatic synthesis of LDL cholesterol and triglycerides, and increasing HDL. It is indicated for the treatment of primary hypercholesterolemia, mixed dyslipidemia, and for the prevention of major cardiovascular events in patients with high cardiovascular risk factors.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>